Cite Filings / TRDA / 0001950047-23-003747
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Entrada Therapeutics, Inc. · Filed 2023-09-06 · Acc 0001950047-23-003747

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2023-09-06 144 Sale of Securities
  • 2023-09-06 144 Sale of Securities
  • 2023-09-06 144 Sale of Securities
  • 2023-09-06 4 President and CEO gave up 1,440 shares (to pay taxes)
  • 2023-09-06 4 Chief Financial Officer sold 950 shares at an average $13.48 ($12,806)
  • 2023-09-06 4 Chief Medical Officer sold 892 shares at an average $13.48 ($12,022)
  • 2023-08-14 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…